Reported Reactions

Devices › Radioimmunoassay, thyroid-stimulating hormone

Device brand name · Radioimmunoassay thyroid-stimulating hormone

Tsh Thyrotropin: medical device reports filed with FDA

214 reports name it, 2011–2016. Manufacturer given most often on reports: Roche Diagnostics. Product code JLW.

214
device reports naming the brand
0% of all MAUDE reports · about 14 a year
0
reports, 12 months to August 2026
0 in the 12 months before
100%
classified as malfunction
97% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 214 reports that name the brand "Tsh Thyrotropin" (radioimmunoassay thyroid-stimulating hormone), received between May 2011 and August 2016; the manufacturer given most often on reports is Roche Diagnostics. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (100%); across all radioimmunoassay, thyroid-stimulating hormone reports (product code JLW) death is recorded in 0% and malfunction in 97%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are high test results (31.3%), incorrect or inadequate test results (30.8%) and low test results (26.6%). FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Tsh Thyrotropin was received in the five years to August 2026; the latest was received in August 2016.

By year received

0551102011: 1020112012: 420122013: 720132014: 3320142015: 11020152016: 502016

Event type and report source

Event type, as classified on the report

Death0%0
Injury0%0
Malfunction100%214
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%214
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 2,774 reports carrying product code JLW. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
High test results6731.3%35.6%
Incorrect or inadequate test results6630.8%13.2%
Low test results5726.6%42.4%
Incorrect, inadequate or imprecise result or readings31.4%4.7%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

In context

MeasureTsh ThyrotropinProduct code JLWAll MAUDE reports
Reports2142,77426,136,888
Share of that pool—7.7%0%
Classified as death, per 1,000 reports009
Classified as injury0%2.6%36.2%
Classified as malfunction100%97%62.3%
Filed by the manufacturer100%99.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code JLW

BrandReportsLatest 12 monthsClassified as death
Vitros Immunodiagnostic Products Tsh Reagent Pack537320%
Elecsys Tsh Assay52900%
Architect Tsh196150%
Elecsys Tsh15790%
Dimension Clinical Chemistry System1,89500.2%
Architect I2000sr Analyzer1,78500.1%
Analytical E Module77200%
Dimension Vista68280%
Unicel Dxl800 Access Immunoassay System25000%
Unicel Dxi 600 Access Immunoassay System28900%
cobas 6000 e601 module902850%
Access Immunoassay System25800%
Cobas E411 Disk System28500%
Immulite 2000 Xpi454100%
Dimension R Clinical Chemistry System39900%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Tsh Thyrotropin reports

How many FDA reports name Tsh Thyrotropin?

214 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

high test results (31.3%), incorrect or inadequate test results (30.8%), low test results (26.6%) and incorrect, inadequate or imprecise result or readings (1.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Tsh Thyrotropin was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.